Corcept Therapeutics Inc. buy Canaccord Genuity Group Inc.
Start price
08.03.23
/
50%
€19.83
Target price
08.03.24
€30.31
Performance (%)
7.94%
End price
09.03.24
€21.40
Summary
This prediction ended on 09.03.24 with a price of €21.40. The BUY prediction by Canaccord_Genuity_Gr finished with a performance of 7.94%. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Corcept Therapeutics Inc. | -4.091% | -4.091% | -44.253% | 40.791% |
| iShares Core DAX® | -1,34 % | -5,62 % | 3,38 % | 51,20 % |
| iShares Nasdaq 100 | -1,07 % | 2,60 % | 19,13 % | 93,73 % |
| iShares Nikkei 225® | -1,99 % | -6,51 % | 27,85 % | 51,19 % |
| iShares S&P 500 | -1,32 % | 0,91 % | 14,19 % | 65,29 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $33.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for CORT provided by MarketBeat
In the thread Trading Corcept Therapeutics Inc.
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten